Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
274.93B
Market cap274.93B
Price-Earnings ratio
14.59
Price-Earnings ratio14.59
Dividend yield
2.97%
Dividend yield2.97%
Average volume
12.07M
Average volume12.07M
High today
$110.95
High today$110.95
Low today
$109.50
Low today$109.50
Open price
$110.12
Open price$110.12
Volume
1.42M
Volume1.42M
52 Week high
$112.90
52 Week high$112.90
52 Week low
$73.31
52 Week low$73.31

Stock Snapshot

With a market cap of 274.93B, Merck(MRK) trades at $110.75. The stock has a price-to-earnings ratio of 14.59 and currently yields dividends of 3.0%.

As of 2026-02-02, Merck(MRK) stock has fluctuated between $109.50 and $110.95. The current price stands at $110.75, placing the stock +1.1% above today's low and -0.2% off the high.

The Merck(MRK)'s current trading volume is 1.42M, compared to an average daily volume of 12.07M.

In the last year, Merck(MRK) shares hit a 52-week high of $112.90 and a 52-week low of $73.31.

In the last year, Merck(MRK) shares hit a 52-week high of $112.90 and a 52-week low of $73.31.

MRK News

Simply Wall St 17h
How Investors May Respond To Merck Prioritizing Oncology Partnerships Over Mega-Deals

In late January 2026, Merck confirmed a US$0.85 per-share quarterly dividend for the second quarter and walked away from Revolution Medicines acquisition talks...

How Investors May Respond To Merck Prioritizing Oncology Partnerships Over Mega-Deals
Simply Wall St 2d
Merck Valuation Check As New Oncology Deals With Eikon And Guardant Reshape Its Cancer Strategy

Merck (MRK) has moved to deepen its oncology footprint by committing a $30 million investment for nearly a 10% stake in Eikon Therapeutics, and by signing a mul...

Merck Valuation Check As New Oncology Deals With Eikon And Guardant Reshape Its Cancer Strategy
Simply Wall St 3d
Merck Ends Revolution Talks As Oncology Focus And Valuation Take Center Stage

Merck (NYSE:MRK) has ended acquisition talks with Revolution Medicines after the two sides did not agree on valuation. The canceled discussions relate to a pot...

Merck Ends Revolution Talks As Oncology Focus And Valuation Take Center Stage

Analyst ratings

55%

of 29 ratings
Buy
55.2%
Hold
44.8%
Sell
0%

More MRK News

TipRanks 5d
Merck expected to buy roughly 10% of shares in Eikon’s IPO, Bloomberg says

Merck (MRK) is anticipated to purchase roughly 10% of the shares in Eikon Therapeutics’ (EIKN) upcoming IPO, Bloomberg’s Anthony Hughes reports, citing people f...

Seeking Alpha 5d
Merck veteran-led Eikon seeks $908M valuation in U.S. IPO ‍

Eikon ‍Therapeutics (EIKN), a cancer drug developer led by Merck (MRK) veteran Roger Perlmutter, has filed for its U.S. IPO seeking a valuation of up to $908M w...

Merck veteran-led Eikon seeks $908M valuation in U.S. IPO ‍
The Motley Fool 7d
Why Revolution Medicines Stock Plummeted by Almost 17% Today

It doesn't look like the company will end up in the arms of an acquirer soon, after all. Monday was generally a good day for the stock market; nevertheless, so...

Why Revolution Medicines Stock Plummeted by Almost 17% Today
Simply Wall St 7d
Is Merck Offering Value After Recent Share Price Pause And DCF Upside Signals

If you are wondering whether Merck is fairly priced or still offers value at its current share price, this article walks through the key numbers that matter to...

Is Merck Offering Value After Recent Share Price Pause And DCF Upside Signals

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.